SHANGHAI NO.1 PHARMACY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.2 CNY | -.--% |
|
+0.09% | -6.82% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,037 | 2,099 | 2,171 | 2,086 | 2,516 | 2,681 |
| Enterprise Value (EV) 1 | 1,671 | 1,626 | 1,841 | 1,926 | 2,209 | 2,452 |
| P/E ratio | 43.5 x | 39.5 x | 31.4 x | 42.5 x | 17.6 x | 30.1 x |
| Yield | 0.71% | 0.8% | 0.98% | 0.75% | 1.73% | 1.04% |
| Capitalization / Revenue | 1.73 x | 1.69 x | 1.37 x | 1.49 x | 0.95 x | 1.47 x |
| EV / Revenue | 1.42 x | 1.31 x | 1.16 x | 1.38 x | 0.83 x | 1.35 x |
| EV / EBITDA | 93.5 x | 40.6 x | 36.6 x | 122 x | 10.4 x | 140 x |
| EV / FCF | 42.7 x | 18 x | 64.9 x | -2,046 x | 26.8 x | 124 x |
| FCF Yield | 2.34% | 5.57% | 1.54% | -0.05% | 3.74% | 0.81% |
| Price to Book | 3.07 x | 2.89 x | 2.92 x | 2.71 x | 2.64 x | 2.68 x |
| Nbr of stocks (in thousands) | 223,086 | 223,086 | 223,086 | 223,086 | 223,086 | 223,086 |
| Reference price 2 | 9.130 | 9.410 | 9.730 | 9.350 | 11.28 | 12.02 |
| Announcement Date | 4/12/19 | 4/13/20 | 3/31/21 | 4/1/22 | 3/31/23 | 3/29/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,177 | 1,243 | 1,587 | 1,398 | 2,656 | 1,820 |
| EBITDA 1 | 17.87 | 40 | 50.35 | 15.73 | 213.2 | 17.57 |
| EBIT 1 | 10.06 | 32.5 | 42.99 | 8.936 | 206.6 | 11.41 |
| Operating Margin | 0.86% | 2.61% | 2.71% | 0.64% | 7.78% | 0.63% |
| Earnings before Tax (EBT) 1 | 59.01 | 68.63 | 90.66 | 65.24 | 190.5 | 117.5 |
| Net income 1 | 47.19 | 53.09 | 68.54 | 49.42 | 143.6 | 89.28 |
| Net margin | 4.01% | 4.27% | 4.32% | 3.53% | 5.41% | 4.91% |
| EPS 2 | 0.2100 | 0.2380 | 0.3100 | 0.2200 | 0.6400 | 0.4000 |
| Free Cash Flow 1 | 39.12 | 90.46 | 28.37 | -0.9413 | 82.52 | 19.81 |
| FCF margin | 3.32% | 7.28% | 1.79% | -0.07% | 3.11% | 1.09% |
| FCF Conversion (EBITDA) | 218.9% | 226.15% | 56.36% | - | 38.71% | 112.79% |
| FCF Conversion (Net income) | 82.91% | 170.4% | 41.4% | - | 57.48% | 22.19% |
| Dividend per Share 2 | 0.0650 | 0.0750 | 0.0950 | 0.0700 | 0.1950 | 0.1250 |
| Announcement Date | 4/12/19 | 4/13/20 | 3/31/21 | 4/1/22 | 3/31/23 | 3/29/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 365 | 474 | 329 | 160 | 308 | 230 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 39.1 | 90.5 | 28.4 | -0.94 | 82.5 | 19.8 |
| ROE (net income / shareholders' equity) | 6.82% | 7.57% | 9.25% | 6.47% | 16.5% | 9.08% |
| ROA (Net income/ Total Assets) | 0.57% | 1.77% | 2.06% | 0.41% | 7.66% | 0.37% |
| Assets 1 | 8,310 | 3,001 | 3,333 | 12,083 | 1,875 | 24,419 |
| Book Value Per Share 2 | 2.970 | 3.250 | 3.330 | 3.460 | 4.270 | 4.490 |
| Cash Flow per Share 2 | 1.740 | 2.120 | 2.280 | 1.180 | 2.260 | 1.790 |
| Capex 1 | 9.13 | 9.99 | 12.2 | 12.6 | 11.4 | 13.9 |
| Capex / Sales | 0.78% | 0.8% | 0.77% | 0.9% | 0.43% | 0.76% |
| Announcement Date | 4/12/19 | 4/13/20 | 3/31/21 | 4/1/22 | 3/31/23 | 3/29/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -6.82% | 345M | |
| -0.73% | 3.44B | |
| -23.44% | 3.15B | |
| +7.98% | 2.76B | |
| +11.98% | 2.71B | |
| -9.90% | 1.79B | |
| +11.26% | 1.43B | |
| -20.03% | 974M | |
| -37.98% | 710M | |
| -0.53% | 454M |
- Stock Market
- Equities
- 600833 Stock
- Financials Shanghai No.1 Pharmacy Co.,Ltd.